Aluminum Compounds for Use in Therapeutics and Vaccines
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 5 of these applications claim priority to application 13/449,596, filed Apr 18, 2012. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 9,884,115 | Aluminum Compounds for Use in Therapeutics and Vaccines In force · High confidence | Valneva Austria GmbH | In force | High confidence | ||
| US 9,895,437 | Aluminum Compounds for Use in Therapeutics and Vaccines In force · High confidence | Valneva Austria GmbH | In force | High confidence | ||
| US 10,668,146 | Methods for Preparing Aluminum Precipitate Compounds for Use in Therapeutics and Vaccines In force · High confidence | Valneva Austria GmbH | In force | High confidence | ||
| US 11,110,170 | Aluminum Compounds for Use in Therapeutics and Vaccines In force · High confidence | Valneva Austria GmbH | In force | High confidence | ||
| US 12,527,863 | Methods for Preparing Aluminum Precipitate Compounds for Use in Therapeutics and Vaccines In force · High confidence | Valneva Austria GmbH | In force | High confidence | ||
| US 9,913,898 | Aluminum Compounds for Use in Therapeutics and Vaccines In force · High confidence | Valneva Austria GmbH | In force | High confidence | ||
| Application 19/411,478 | Methods for Preparing Aluminum Precipitate Compounds for Use in Therapeutics and Vaccines Pending Not granted | Valneva Austria GmbH | Pending | Not granted |
7 of 7 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
6 of these are in force and held by Valneva SE.
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.